MI
FBIO icon

Motiv8 Investments’s Fortress Biotech FBIO Stock Holding History

Motiv8 Investments’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$0 Buy
+33
New +$94 ﹤0.01% 934

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Motiv8 Investments's FBIO Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Fortress Biotech (FBIO) in Q4 2025: 33 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #934 among its holdings.

52 funds tracked by Wall St. Rank hold FBIO as of Q4 2025.

  • Motiv8 Investments held 33 shares of Fortress Biotech worth $0 as of Q4 2025.
  • Fortress Biotech was a new Motiv8 Investments position in Q4 2025.
  • Fortress Biotech made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #934 holding.
  • 52 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.